KEVIN BRUCE

Chief Operating Officer, Roslin Cell Therapies Ltd

Kevin is Chief Operating Officer at Roslin Cell Therapies Ltd. Kevin has more than 20 years’ experience working in a regulated life science environment and has held positions in Operations, Quality, R&D and commercial development for small biotech, large CROs and SMEs. With over 15 years’ experience in stem cells and ATMPS, Kevin was previously Head of Development Operations for Roslin Cells’ with the responsibility for collaborations across development, GMP translation and manufacture of cell therapies for both pre-clinical and clinical development. More recently, as COO at Censo Biotechnologies, he established the operational capability for the European Bank for induced Pluripotent Stem Cells (EBiSC) and was responsible for Censo’s stem cell generation, genome editing and assay development operations for drug discovery. Today, Kevin is responsible for operations and building the team at RoslinCT, a rapidly expanding UK based CDMO delivering life changing cell and gene therapies globally.